| 来源类型 | Working Paper
|
| 规范类型 | 报告
|
| DOI | 10.3386/w17371
|
| 来源ID | Working Paper 17371
|
| Comparative Effectiveness Research, COURAGE, and Technological Abandonment |
| David H. Howard; Yu-Chu Shen
|
| 发表日期 | 2011-08-25
|
| 出版年 | 2011
|
| 语种 | 英语
|
| 摘要 | When a major study finds that a widely used medical treatment is no better than a less expensive alternative, do physicians stop using it? Policymakers hope that comparative effectiveness research will identify less expensive substitutes for widely-used treatments, but physicians may be reluctant to abandon profitable therapies. We examine the impact of the COURAGE trial, which found that medical therapy is as effective as percutaneous coronary intervention (PCI) for patients with stable angina, on practice patterns. Using hospital discharge data from US community, Veterans Administration, and English hospitals, we detect a moderate decline in PCI volume post-COURAGE. However, many patients with stable angina continue to receive PCI. We do not find differences in PCI volume trends by reimbursement scheme or hospitals' teaching status, ownership, or degree of vertical integration. |
| 主题 | Health, Education, and Welfare
; Health
; Development and Growth
; Innovation and R&
; D
|
| URL | https://www.nber.org/papers/w17371
|
| 来源智库 | National Bureau of Economic Research (United States)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/575045
|
推荐引用方式
GB/T 7714 |
David H. Howard,Yu-Chu Shen. Comparative Effectiveness Research, COURAGE, and Technological Abandonment. 2011.
|
|
文件名：
|
w17371.pdf
|
|
格式：
|
Adobe PDF
|
此文件暂不支持浏览
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
